Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001574368 | SCV001801177 | likely benign | not provided | 2019-09-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002072250 | SCV002420328 | likely benign | Hereditary spastic paraplegia 63; Pontocerebellar hypoplasia type 9 | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003346621 | SCV004050597 | likely benign | Hereditary spastic paraplegia 63 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003346622 | SCV004050598 | likely benign | Pontocerebellar hypoplasia type 9 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003931214 | SCV004740454 | likely benign | AMPD2-related disorder | 2022-06-29 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |